News

Click to see a preview of what to expect this week.

Don't Forget to take this week's poll.

ICYMI, some of this week’s featured content includes an exclusive interview about the occupational dermatoses, and articles on 2021's breakthroughs and disappointments, the risk of psoriasis related to BMI and more.

Click to see a preview of what to expect this week.

Click here to answer this week's poll.

ICYMI, some of this week’s featured content includes an exclusive interview about the iPLEDGE program issues, and articles on FDA approval of upadacitinib for psoriatic arthritis, ruxolitinib cream receiving Priority Review from the FDA for vitiligo, and more.

John Barbieri, MD, MBA, FAAD, speaking in his capacity as a member of the AADA iPLEDGE Workgroup, talks with Dermatology Times® about the recent iPLEDGE website struggles and guidance on how dermatologists should handle the situation.

Klint Peebles, MD, FAAD, co-chair of the AAD LGBTQ/SGM Expert Resource Group, sits down with Dermatology Times® to discuss what changes were made to the iPLEDGE platform, examples of how the roll out has been unsuccessful, and how patients should be wary of trying to take old medications.

In this video interview, Klint Peebles, MD, FAAD, co-chair of the AAD LGBTQ/SGM Expert Resource Group, explains what happened with the iPLEDGE website.

Physicians and their teams have been unable to access the iPLEDGE site during an update to incorporate an FDA-approved modification to the iPLEDGE REMS that took effect December 13, 2021.

Arcutis Biotherapeutics has announced data suggesting that the vehicle in the investigational roflumilast cream had similar moisturizing properties as a commercially marketed, dermatologist-recommended, ceramide-containing moisturizer in adults with mild eczema.

Click to see a preview of what to expect this week.

ICYMI, some of this week’s featured content includes an exclusive interview about the unmet needs of vitiligo patients, and articles on international impetigo guidelines, the newly released tapinarof data, and more.

A new study in the Journal of General Internal Medicine finds compliance remains lacking a year after federal price transparency rules went into effect.

Telehealth visits increased, but overall utilization of Part B declined

A new study on the gender pay gap in medicine examined earnings data from more than 80,000 doctors.

This week’s edition of The Mainstream Patient features stories about a diet to manage psoriasis symptoms, face steaming, and more.

Click here to answer this week's poll.

Click to see a preview of what to expect this week.

ICYMI, some of this week’s featured content includes an exclusive interview about the clinical implications of JAK inhibitors, and articles on trending skincare, Galderma, and more.

COVID-19 is prompting significant changes to malpractice laws and regulations at the state and federal levels.

In this week's podcast, we sit down with from the OJM Group to discuss qualified retirement plans and how dermatology practices may be able to save money.

The Omicron variant of COVID-19 is spreading quickly, jumping continents with infected travelers. Here’s the latest on what global health officials know about it.

Each month, Dermatology Times® features a roundup of products trending in skin care. Click here to find out what products are trending for the month of November.

A preview at what to expect from Dermatology Times this week.

This week’s edition of The Mainstream Patient features stories about probiotic skincare, how to manage dry skin, and more.

Click here to answer this week's poll

ICYMI, some of this week’s featured content includes an exclusive interview the science behind JAK inhibitors, and articles on the financial burden of wound care, the Procter and Gamble voluntary recall, and more.

Racial and ethnic inequities persist in all 50 states.

Procter & Gamble have issued a voluntary recall of specific Old Spice and Secret brand aerosol antiperspirants and Old Spice Below Deck aerosol spray due to benzene detection.